148.17
-1.57(-1.05%)
Currency In USD
| Previous Close | 149.74 |
| Open | 147.94 |
| Day High | 148.73 |
| Day Low | 146.83 |
| 52-Week High | 219.34 |
| 52-Week Low | 122.8 |
| Volume | 205,585 |
| Average Volume | 360,170 |
| Market Cap | 4.28B |
| PE | 35.62 |
| EPS | 4.16 |
| Moving Average 50 Days | 137.83 |
| Moving Average 200 Days | 163.91 |
| Change | -1.57 |
If you invested $1000 in Krystal Biotech, Inc. (KRYS) since IPO date, it would be worth $13,925.75 as of July 12, 2025 at a share price of $148.17. Whereas If you bought $1000 worth of Krystal Biotech, Inc. (KRYS) shares 5 years ago, it would be worth $3,923.99 as of July 12, 2025 at a share price of $148.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
GlobeNewswire Inc.
Jul 09, 2025 11:00 AM GMT
Eye drop administration of KB801 designed to enable sustained expression of NGF in the front of the eye Investor call and webcast to be held July 9 at 8:30 am ET to discuss program and trial design PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krys
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
GlobeNewswire Inc.
Jun 24, 2025 11:00 AM GMT
Intra-patient, double-blind, multicenter, placebo-controlled study with crossover design Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing by 3 months as well as significa
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
Jun 03, 2025 12:00 PM GMT
PITTSBURGH, June 03, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, in Miami. Krish S.